174 related articles for article (PubMed ID: 1692008)
1. The histogenetic origin of cervical mesonephric hyperplasia and mesonephric adenocarcinoma of the uterine cervix studied with immunohistochemical methods.
Lang G; Dallenbach-Hellweg G
Int J Gynecol Pathol; 1990; 9(2):145-57. PubMed ID: 1692008
[TBL] [Abstract][Full Text] [Related]
2. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
3. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
4. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases.
Ferry JA; Scully RE
Am J Surg Pathol; 1990 Dec; 14(12):1100-11. PubMed ID: 2252101
[TBL] [Abstract][Full Text] [Related]
5. Cervical adenocarcinoma arising in florid mesonephric hyperplasia: report of a case with immunocytochemical studies.
Valente PT; Susin M
Gynecol Oncol; 1987 May; 27(1):58-68. PubMed ID: 2436982
[TBL] [Abstract][Full Text] [Related]
6. Florid mesonephric hyperplasia of the cervix: a report of a case with review of the literature.
Ayroud Y; Gelfand MM; Ferenczy A
Int J Gynecol Pathol; 1985; 4(3):245-54. PubMed ID: 2414240
[TBL] [Abstract][Full Text] [Related]
7. Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.
Goyal A; Yang B
Int J Gynecol Pathol; 2014 Nov; 33(6):613-9. PubMed ID: 25272301
[TBL] [Abstract][Full Text] [Related]
8. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.
Ordi J; Nogales FF; Palacin A; Márquez M; Pahisa J; Vanrell JA; Cardesa A
Am J Surg Pathol; 2001 Dec; 25(12):1540-5. PubMed ID: 11717545
[TBL] [Abstract][Full Text] [Related]
9. Immunopathological study of mesonephric lesions of cervix uteri and vagina.
Kondi-Pafitis A; Kairi E; Kontogianni KI; Dimopoulou C; Sikiotis K; Smyrniotis V
Eur J Gynaecol Oncol; 2003; 24(2):154-6. PubMed ID: 12701967
[TBL] [Abstract][Full Text] [Related]
10. Mesonephric adenocarcinoma (endometrioid type) of endocervix with diffuse mesonephric hyperplasia involving cervical wall and myometrium: an unusual case report.
Menon S; Kathuria K; Deodhar K; Kerkar R
Indian J Pathol Microbiol; 2013; 56(1):51-3. PubMed ID: 23924560
[TBL] [Abstract][Full Text] [Related]
11. Female adnexal tumours of probable Wolffian origin: an immunohistochemical study comparing tumours, mesonephric remnants and paramesonephric derivatives.
Tiltman AJ; Allard U
Histopathology; 2001 Mar; 38(3):237-42. PubMed ID: 11260305
[TBL] [Abstract][Full Text] [Related]
12. Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component.
Clement PB; Young RH; Keh P; Ostör AG; Scully RE
Am J Surg Pathol; 1995 Oct; 19(10):1158-71. PubMed ID: 7573674
[TBL] [Abstract][Full Text] [Related]
13. Mesonephric adenocarcinoma of the uterine cervix with focal endocrine cell differentiation.
Stewart CJ; Taggart CR; Brett F; Mutch AF
Int J Gynecol Pathol; 1993 Jul; 12(3):264-9. PubMed ID: 7688354
[TBL] [Abstract][Full Text] [Related]
14. Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings.
Silver SA; Devouassoux-Shisheboran M; Mezzetti TP; Tavassoli FA
Am J Surg Pathol; 2001 Mar; 25(3):379-87. PubMed ID: 11224609
[TBL] [Abstract][Full Text] [Related]
15. Mesonephric remnant hyperplasia of the cervix: a clinicopathologic analysis of 14 cases.
Jones MA; Andrews J; Tarraza HM
Gynecol Oncol; 1993 Apr; 49(1):41-7. PubMed ID: 8482559
[TBL] [Abstract][Full Text] [Related]
16. Mesonephric adenocarcinoma of the uterine cervix: A case report and review of the literature.
Tekin L; Yazici A; Akbaba E; Akin MN
J Pak Med Assoc; 2015 Sep; 65(9):1016-7. PubMed ID: 26338754
[TBL] [Abstract][Full Text] [Related]
17. Urethral obstruction due to lobular mesonephric hyperplasia of the vagina--a case report.
Handoo A; Kini H; Pai R; Prabhu GG
Indian J Pathol Microbiol; 2005 Jan; 48(1):20-1. PubMed ID: 16758778
[TBL] [Abstract][Full Text] [Related]
18. Mesonephric rest hyperplasia. A potential diagnostic pitfall.
Amin-Hanjani S; Paulson J; Henien S; Hanjani P
Arch Pathol Lab Med; 1991 Oct; 115(10):1059-61. PubMed ID: 1898238
[TBL] [Abstract][Full Text] [Related]
19. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
Kenny SL; McBride HA; Jamison J; McCluggage WG
Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
[TBL] [Abstract][Full Text] [Related]
20. Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis.
Cavalcanti MS; Schultheis AM; Ho C; Wang L; DeLair DF; Weigelt B; Gardner G; Lichtman SM; Hameed M; Park KJ
Int J Gynecol Pathol; 2017 Jan; 36(1):76-89. PubMed ID: 27532149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
